Abstract
We report on the potency of two Tyrphostin tyrosine kinase blockers, AG 1112 and AG 568, to inhibit p210(bcr-abl) tyrosine kinase activity in K562 cells, concomitant with the induction of erythroid differentiation. AG 568 and especially AG 1112 represent a specific group of nontoxic protein tyrosine kinase blockers among more than 1,400 tested. These compounds possess therapeutic potential for purging Philadelphia chromosome-positive cells in preparation for autologous bone marrow transplantation in chronic myelogenous leukemia.
| Original language | English |
|---|---|
| Pages (from-to) | 3524-3529 |
| Number of pages | 6 |
| Journal | Blood |
| Volume | 82 |
| Issue number | 12 |
| DOIs | |
| State | Published - 1993 |